Clover Health lost $22M in 2017, a slight improvement from the previous year

screenshot of Clover Health website
Alphabet-backed Clover Health has stemmed its losses since 2016, but it's not turning a profit. (Clover)

The highly-valued health insurance startup Clover Health pared back its losses in 2017, but the company is still struggling to turn a profit.

The company lost $22 million in 2017, according to Bloomberg, a slight improvement from the $35 million it lost in 2016. Revenue grew from $184 million in 2016 to $267 million last year. The insurer's star rating has also dropped from 3.5 to 3 this year.

Backed by the likes of Google’s parent company, Alphabet, and Greenoaks Capital, Clover was last valued at $1.2 billion following a $130 million funding round last year. All told, investors poured $425 million into the insurance startup that had focused exclusively on Medicare Advantage plans in New Jersey.

Innovation Awards

Submit your nominations for the FierceHealthcare Innovation Awards

The FierceHealthcare Innovation Awards showcases outstanding innovation that is driving improvements and transforming the industry. Our expert panel of judges will determine which companies demonstrate innovative solutions that have the greatest potential to save money, engage patients, or revolutionize the industry. Deadline for submissions is this Friday, October 18th.

RELATED: Clover Health co-founder to step down from his post

After limiting its plans to one state for several years, the company announced in December that it would expand to Georgia, Texas and Pennsylvania. Clover relies on a data-driven strategy that leans on predictive analytics to provide necessary information to providers about high-risk patients.

But it’s been a bumpy ride for the insurer over the last several years. The company was fined by the Center for Medicare and Medicaid Services (CMS) in 2016 for “misleading” marketing tactics after receiving a high volume of complaints from enrollees. Last month, a CNBC report revealed that Clover delayed paying bills to laboratories as leverage to collect patient data. The company also fell well short of its early projections for both revenue and membership.

In December, chief technology officer and co-founder Kris Gale stepped down from his role to serve as an adviser.

Suggested Articles

As the public debate on health reform rolls on, a new report analyzes how these different approaches could impact insurers' bottom lines.

A House panel is going to consider several changes to Nancy Pelosi's drug prices plan, including stiff penalties for not being transparent.

Molina aims to bolster its Medicaid business by acquiring certain assets from New York-based YourCare for $40 million.